Equities

Brightspring Health Services Inc

BTSG:NSQ

Brightspring Health Services Inc

Actions
Health CareHealth Care Providers
  • Price (USD)19.57
  • Today's Change0.65 / 3.44%
  • Shares traded1.77m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy4
Outperform7
Hold1
Sell0
Strong Sell0

Share price forecast in USD

The 11 analysts offering 12 month price targets for Brightspring Health Services Inc have a median target of 20.00, with a high estimate of 23.00 and a low estimate of 17.00. The median estimate represents a 2.20% increase from the last price of 19.57.
High17.5%23.00
Med2.2%20.00
Low-13.1%17.00

Earnings history & estimates in USD

On Nov 01, 2024, Brightspring Health Services Inc reported 3rd quarter 2024 earnings of 0.11 per share.
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate-6.98%
Brightspring Health Services Inc reported annual 2023 earnings of 0.28 per share on Feb 29, 2024.
More ▼

Revenue history & estimates in USD

Brightspring Health Services Inc had 3rd quarter 2024 revenues of 2.91bn. This bettered the 2.72bn consensus of the 10 analysts covering the company. This was 22.42% above the prior year's 3rd quarter results.
Average growth rate+6.98%
Brightspring Health Services Inc had revenues for the full year 2023 of 8.83bn. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.